HCV DAAs & HCC

Published: 17 May 2020| Version 2 | DOI: 10.17632/8ws8258hn3.2
Contributors:
Ahmad Zidan,
Eman Saad,
medhat hashem,
Nasser Ibrahim,
Amal Mahmoud,
Alaa Hemeida

Description

Results from application of PHARMIP insilico pipeline to 16 direct acting anti-HCV drugs from 3 drug classes

Files